BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30114927)

  • 21. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.
    Lang N; Yuan H; Yu HJ; Su MY
    Acad Radiol; 2017 Jul; 24(7):867-875. PubMed ID: 28162875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours.
    Manganaro L; Saldari M; Pozza C; Vinci V; Gianfrilli D; Greco E; Franco G; Sergi ME; Scialpi M; Catalano C; Isidori AM
    Eur Radiol; 2018 Feb; 28(2):554-564. PubMed ID: 28856410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The roles of the diffusion-weighted imaging in orbital masses.
    Phuttharak W; Boonrod A; Patjanasoontorn N; Peansukwech U; Sawanyawisuth K
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):753-758. PubMed ID: 28664638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging.
    Wang F; Sha Y; Zhao M; Wan H; Zhang F; Cheng Y; Tang W
    J Comput Assist Tomogr; 2017; 41(2):199-205. PubMed ID: 27560026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
    Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
    J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.
    Lang N; Su MY; Xing X; Yu HJ; Yuan H
    J Magn Reson Imaging; 2017 Apr; 45(4):1068-1075. PubMed ID: 27490009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantifying tumor vascular heterogeneity with DCE-MRI in complex adnexal masses: A preliminary study.
    Thomassin-Naggara I; Soualhi N; Balvay D; Darai E; Cuenod CA
    J Magn Reson Imaging; 2017 Dec; 46(6):1776-1785. PubMed ID: 28370815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion Weighted Imaging for Differentiating Benign from Malignant Orbital Tumors: Diagnostic Performance of the Apparent Diffusion Coefficient Based on Region of Interest Selection Method.
    Xu XQ; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Korean J Radiol; 2016; 17(5):650-6. PubMed ID: 27587953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation between benign and malignant ovarian masses using multiparametric MRI.
    Türkoğlu S; Kayan M
    Diagn Interv Imaging; 2020 Mar; 101(3):147-155. PubMed ID: 31987805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of focal indeterminate marrow abnormalities with multiparametric MRI.
    Baik JS; Jung JY; Jee WH; Chun CW; Kim SK; Shin SH; Chung YG; Jung CK; Kannengiesser S; Sohn Y
    J Magn Reson Imaging; 2017 Jul; 46(1):49-60. PubMed ID: 27859835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging biomarkers in the diagnosis of salivary gland tumors: the value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters.
    Mungai F; Verrone GB; Bonasera L; Bicci E; Pietragalla M; Nardi C; Berti V; Mazzoni LN; Miele V
    Radiol Med; 2021 Oct; 126(10):1345-1355. PubMed ID: 34181206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.
    Spanakis M; Kontopodis E; Van Cauter S; Sakkalis V; Marias K
    J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):529-47. PubMed ID: 27647272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The value of dynamic contrast-enhanced MRI in the differentiation between benign and malignant lacrimal epithelial tumors].
    Wang YZ; Xian JF; Wang XY; Guo J; Song LY
    Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(31):2427-2432. PubMed ID: 37599217
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of Temporal Resolution on Diagnostic Performance of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate.
    Othman AE; Falkner F; Weiss J; Kruck S; Grimm R; Martirosian P; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 May; 51(5):290-6. PubMed ID: 26619282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
    Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
    Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility and value of quantitative dynamic contrast enhancement MR imaging in the evaluation of sinonasal tumors.
    Xian J; Du H; Wang X; Yan F; Zhang Z; Hao H; Zhao B; Tong Y; Zhang J; Han D
    Chin Med J (Engl); 2014; 127(12):2259-64. PubMed ID: 24931238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
    Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
    Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.